Table 1. Clinical characteristics of patients with adult bleeding Meckel’s diverticulum.
| Bleeding Meckel’s diverticulum (n = 35) | |
|---|---|
| Demographics | |
| Age (years), mean ± S.D. | 37.2 ± 15.7 |
| < 40 years, n (%) | 22 (62.9) |
| Male gender, n (%) | 25 (71.4) |
| Clinical manifestation | |
| Overt small bowel bleeding, n (%) | 27 (77.1) |
| Obscure small bowel bleeding, n (%) | 8 (22.9) |
| Medical history | |
| Aspirin or NSAID use, n (%) | 3 (8.6) |
| Comorbidity, n (%) | 8* (17.1) |
| History of previous OGIB, n (%) | 16 (45.7) |
| Laboratory results | |
| Hemoglobin (g/dL), mean ± S.D. | 9.7±2.9 |
| Hematocrit (%), mean ± S.D. | 29.1±9.0 |
| Platelet (1,000 cells/mm3), mean ± S.D. | 219.9±868.5 |
| PT (INR), mean ± S.D. | 1.1±0.1 |
| Surgery | |
| Laparoscopy vs. open laparotomy | |
| Laparoscopy, n (%) | 13 (34.2) |
| Open laparotomy, n (%) | 22 (65.8) |
| Type | |
| Small bowel resection and anastomosis, n (%) | 28 (80.0) |
| Diverticulectomy, n (%) | 7 (20.0) |
| Post-operative complications, n (%) | 0 (0) |
| Pathology | |
| Ectopic tissue in diverticulum, n (%) | 24 (68.6) |
| Gastric tissue, n (%) | 22 (62.9) |
| Pancreatic tissue, n (%) | 2 (5.7) |
| Prognosis | |
| Post-surgical symptom recurrence, n (%) | 0 (0.0) |
Abbreviation: NSAID, non-steroidal anti-inflammatory drugs; S.D., standard deviation.
*Hypertension (n = 2), type II diabetes (n = 2), schizophrenia (n = 1), chronic hepatitis B (n = 1), chronic hepatitis C (n = 1), previous chemotherapy due to diffuse large B cell lymphoma (n = 1)